NanoVation Therapeutics is a Vancouver-based biotechnology company developing long‑circulating lipid nanoparticle (lcLNP™) technology for genetic medicines. Founded on proprietary lipid chemistry and LNP engineering expertise, NanoVation’s platform enables functional delivery to extrahepatic tissues including immune cells, bone marrow, and tumors, without the need for targeting ligands. The company partners with pharmaceutical and biotech organizations to advance mRNA, DNA, and gene editing programs that require delivery beyond the liver.
For more information, visit nanovationtx.com.
Scientist III, Preclinical – 12‑month contract. Reporting to the Senior Scientist II, Preclinical – Team Lead, the Scientist III, Preclinical will design, execute, analyze, and provide recommendations on preclinical research to advance our projects.
Take the next step and apply for this exciting opportunity
Apply Now